Qingdao Baheal Medical Inc
SZSE:301015
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Qingdao Baheal Medical Inc
Other Current Liabilities
Qingdao Baheal Medical Inc
Other Current Liabilities Peer Comparison
1099
601607
600998
000963
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
Q
|
Qingdao Baheal Medical Inc
SZSE:301015
|
Other Current Liabilities
¥269.1m
|
CAGR 3-Years
11%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Other Current Liabilities
¥13.2B
|
CAGR 3-Years
14%
|
CAGR 5-Years
12%
|
CAGR 10-Years
40%
|
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Other Current Liabilities
¥9B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
14%
|
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Other Current Liabilities
¥6.7B
|
CAGR 3-Years
9%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
33%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Other Current Liabilities
¥2.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
21%
|
CAGR 10-Years
22%
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Other Current Liabilities
¥2.8B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
14%
|
See Also
What is Qingdao Baheal Medical Inc's Other Current Liabilities?
Other Current Liabilities
269.1m
CNY
Based on the financial report for Dec 31, 2023, Qingdao Baheal Medical Inc's Other Current Liabilities amounts to 269.1m CNY.
What is Qingdao Baheal Medical Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
14%
Over the last year, the Other Current Liabilities growth was 31%. The average annual Other Current Liabilities growth rates for Qingdao Baheal Medical Inc have been 11% over the past three years , 14% over the past five years .
You don't have any saved screeners yet
